Health Economics Research Group (HERG)

The Health Economics Research Group (HERG) has developed an international reputation in health economics, building on strong foundations and a consistent strategy pursued over more than twenty-five years.

HERG's strategic focus is on the economic evaluation of a broad range of clinical and health service technologies and its dual aim is to provide applied, policy-relevant research whilst developing and refining methods to increase the rigour and relevance of such studies.

This strategy is highly relevant as economic evaluation begins to play more and more influential roles in international and national policies on the adoption and use of specific technologies.

Members of HERG present research at joint iHEA & ECHE Congress

News item

Dr Louise Longworth presents research on the cost-effectiveness of non-invasive diagnostic tests for assessing fibrosis and cirrhosis in patients in Hepatitis C and Catriona Crossan presents findings of research modelling prioritisation strategies for cardiovascular risk assessment.

HERG organised sessions in iHEA & ECHE Congress

News item

Researchers from HERG are organising two sessions in the forthcoming 10th World Congress Health Economics in the Age of Longevity, a Joint iHEA & ECHE Congress in Dublin, Ireland.

Page last updated: Friday 29 August 2014